Search
Filter Results
- Resource Type
- Article1
- Atlases, Pictorial1
- Book1
- Book Digital1
- Article Type
- Case Reports1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- S Afr Med J1
Search Results
Sort by
- BookTommaso Scarabino, editor ; in collaboration with Ferdinando Caranci ... [and others].Summary: This atlas is a detailed guide to the imaging appearances of gliomas following treatment with neurosurgery, radiation therapy, and chemotherapy. Normal and pathological findings are displayed in detailed MR images that illustrate the potential modifications due to treatment. Particular emphasis is placed on characteristic appearances on the newer functional MR imaging techniques, including MR spectroscopy, diffusion-weighted imaging, and perfusion imaging. These techniques are revolutionizing neuroradiology by going beyond the demonstration of macroscopic alterations to the depiction of preceding metabolic changes at the cellular and subcellular level, thereby allowing earlier and more specific diagnosis. A key section comprising some 40 clinical cases and more than 500 illustrations offers an invaluable clinical and research tool not only for neuroradiologists but also for neurosurgeons, radiotherapists, and medical oncologists.
Contents:
Introduction
Classification
Gliomas
Etiology
Heredity
Risk factors
Pathogenesis
Prognostic factors
Complications
Signs and symptoms
Diagnosis and follow-up
Supportive therapy
Treatment of gliomas
Surgery
Radiotherapy
Chemotherapy
Post-treatment neuroradiological imaging.-Morphological magnetic resonance
Functional magnetic resonance: Spectroscopy
Diffusion
Perfusion
Cortical activation
Clinical cases
Bibliography.Digital Access Springer 2012 - ArticleAdam A, Berson D, Levine C, Marchand P.S Afr Med J. 1977 Apr 23;51(17):594-6.A 20-year-old Coloured woman presented on three occasions with recurrent right-sided spontaneous pneumothorax which proved to be associated with pulmonary histiocytosis X. After corticosteroid therapy there was no recurrence of pneumothorax or radiographic evidence of progressive disease during a 6-month follow-up period.